The T‐type calcium channel antagonist, Z944, reduces spinal excitability and pain hypersensitivity

Erika K. Harding(University of Calgary), Michael E. Hildebrand(Ottawa Hospital), Robert P. Bonin(University of Toronto), Annemarie Dedek(University of Waterloo), Terrance P. Snutch(University of British Columbia), Michael W. Salter(University of Toronto)
British Journal of Pharmacology
April 19, 2021
Cited by 53


Related Papers